Catalyst Wire Dossier Catalyst Wire Dossier

PERSERIS

RISPERIDONE · Indivior Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PERSERIS, covering 2018-07-27 to 2025-01-24. Get the full timeline:

Most recent: FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)

See pricing